Financials in CAD. Standardized financial statements.
A compact view of how BioMark Diagnostics Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $154,216 | $163,220 | $153,492 | $43,933 | $0 | $263,283 | $0 | $0 | $0 | $0 |
| Revenue Growth? | -5.5% | +6.3% | +249.4% | 0.0% | -100.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $0 | $0 | $386,196 | $0 | $13,686 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit? | $154,216 | $163,220 | -$232,704 | $43,933 | -$13,686 | $263,283 | $0 | $0 | $0 | $0 |
| Gross Margin? | +100.0% | +100.0% | -151.6% | +100.0% | 0.0% | +100.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $2.06M | $1.48M | $1.89M | $1.45M | $1.08M | $1.47M | $545,612 | $726,747 | $721,006 | $1.41M |
| Operating Income? | -$1.91M | -$1.32M | -$1.84M | -$1.28M | -$1.09M | -$1.18M | -$545,610 | -$726,747 | -$721,006 | -$1.41M |
| EBITDA? | -$1.46M | -$919,047 | -$1.35M | -$1.22M | -$1.08M | -$1.20M | -$18,751 | -$66,188 | -$25,530 | -$1.40M |
| Income Before Tax | -$1.93M | -$1.43M | -$1.84M | -$1.45M | -$1.09M | -$1.22M | -$545,612 | -$726,747 | -$715,424 | -$1.40M |
| Income Tax Expense | $0 | $0 | $108,292 | $49,683 | $4 | $6,237 | $0 | $0 | -$5,582 | -$4,410 |
| Net Income? | -$1.93M | -$1.43M | -$1.84M | -$1.45M | -$1.09M | -$1.22M | -$545,612 | -$726,747 | -$715,424 | -$1.40M |
| EPS? | $-0.02 | $-0.02 | $-0.02 | $-0.02 | $-0.01 | $-0.02 | $-0.01 | $-0.01 | $-0.01 | $-0.03 |
| Diluted EPS? | $-0.02 | $-0.02 | $-0.02 | $-0.02 | $-0.01 | $-0.02 | $-0.01 | $-0.01 | $-0.01 | $-0.03 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality